0.237
price down icon3.85%   -0.0095
after-market Dopo l'orario di chiusura: .24 0.003 +1.27%
loading

Adial Pharmaceuticals Inc Azioni (ADIL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
16.83%
2.2673
1.9407 2.2115 2.2872 1.845
Operating Income/Loss
16.83%
-2.2673
-1.9407 -2.2115 -2.2872 -1.845
Nonoperating Income/Loss
129.60%
0.0385
-0.1301 0.0197 -0.1711 -4.6315
Income/Loss Before Equity Method Investments
5.29%
-2.0657
-1.962 -2.1608 -2.2358 -6.2867
Income/Loss From Equity Method Investments
49.88%
-0.1631
-0.1088 -0.031 -0.2225 -0.1899
Income/Loss From Continuing Operations Before Tax
7.63%
-2.2288
-2.0708 -2.1918 -2.4583 -6.4766
Income/Loss From Continuing Operations After Tax
7.63%
-2.2288
-2.0708 -2.1918 -2.4583 -6.4766
Net Income/Loss
7.63%
-2.2288
-2.0708 -2.1918 -2.4583 -6.4766
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Diluted Average Shares
1,154%
6.5398
0.5213 5.8357 4.1828 2.9539
Basic Earnings Per Share
126.67%
-0.34
-0.15 -0.38 -0.59 -2.19
Diluted Earnings Per Share
126.67%
-0.34
-0.15 -0.38 -0.59 -2.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$102.71
price up icon 28.63%
$33.90
price up icon 2.42%
$110.57
price up icon 3.67%
$100.08
price up icon 2.03%
biotechnology ONC
$333.87
price up icon 4.22%
$176.00
price up icon 0.53%
Capitalizzazione:     |  Volume (24 ore):